<bill session="119" type="h" number="1142" updated="2025-06-04T19:11:16Z">
  <state datetime="2025-02-07">REFERRED</state>
  <status>
    <introduced datetime="2025-02-07"/>
  </status>
  <introduced datetime="2025-02-07"/>
  <titles>
    <title type="official" as="introduced">To amend the Public Health Service Act to direct the Secretary of Health and Human Services to establish drug adherence guidelines, and for other purposes.</title>
    <title type="display">To amend the Public Health Service Act to direct the Secretary of Health and Human Services to establish drug adherence guidelines, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="S001183"/>
  <cosponsors/>
  <actions>
    <action datetime="2025-02-07">
      <text>Introduced in House</text>
    </action>
    <action datetime="2025-02-07" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referred To"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Advanced technology and technological innovations"/>
    <term name="Medicare"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2025-06-04T19:10:55Z" status="Introduced in House">This bill requires the Centers for Medicare &amp; Medicaid Services (CMS) to establish drug adherence guidelines for covered drugs under Medicare so as to achieve an adherence rate of 90%. The CMS must incorporate artificial&#160;intelligence and machine-learning technologies and promote generics and biosimilars when developing the guidance.</summary>
</bill>
